X-Zyme - Ownership and Business Overview

Life ScienceCompany

X-Zyme Ownership

Who owns X-Zyme?

X-Zyme is owned by Johnson Matthey Pharma Services. It was acquired on April 11, 2011.

X-Zyme Business Overview

What sector is X-Zyme in?

X-Zyme is a life science company.

When was X-Zyme founded?

X-Zyme was founded in 2001.

Life Science M&A Summary in 2011

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Subscribe to Mergr to view all 172 acquisitions of life science companies in 2011, including 23 acquisitions by private equity firms, and 149 by strategics.

X-Zyme GmbH

Life Science Center Merowingerplatz 1A,
Duesseldorf, 40225
+49 211 3398946
www.xzyme.de

X-Zyme, a leading biocatalysis company, provides a full range of enzymes for the manufacture of chiral alcohols. Statistics indicate that currently over 20% of pharmaceutical intermediates contain chiral alcohols.


 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for X-Zyme

Life Science Companies